静脉畸形组织结构与治疗选择的临床分析
收稿日期: 2021-01-26
网络出版日期: 2022-07-27
基金资助
河南省医学科技攻关计划省部共建项目(SB2019 01070)
Clinical analysis on tissue structure and treatment option of venous malformation
Received date: 2021-01-26
Online published: 2022-07-27
目的:根据静脉畸形(venous malformation,VM)组织结构、组织病理特点将病人分成3组,分析治疗方案及对应治疗结果,根据VM组织结构指导治疗方案选择。方法:回顾性分析本院血管瘤科2015年1月至2019年12月170例VM,男73例,女97例,年龄(23.4±9.9)岁。根据标本组织结构将VM分成包膜组141例,非包膜组22例,骨化组7例。超声、磁共振、X线和CT血管造影检查病人。手术或微创治疗VM。术中大体查看和术后VM组织病理检查。术前和出院后行疼痛视觉模拟评分、Oswestry功能障碍指数检测。术后1年随访163例,7例失访。结果:得到3组VM的影像、组织结构与病理表现、治疗方案及疗效评价的数据。包膜组手术101例,治愈78例(77.2%),术后复发2例(2.0%);微创治疗余40例,包括硬化治疗和射频消融,治愈23例(57.5%),复发2例(5.0%),是预后最佳的组织结构类型。非包膜组手术15例,治愈3例(20.0%),复发4例(26.7%);微创治疗余7例,治愈1例,复发3例,复发率高(42.9%)。骨化组均手术治疗,7例治愈,无复发。包膜组和非包膜组出院时疼痛视觉模拟评分较治疗前明显降低。所有病例出院时Oswestry功能障碍指数均较治疗前降低。术后6例发生切口延迟愈合等并发症。结论:组织结构可成为VM治疗方案选择及预后判断的有效依据,包膜组疗效最佳,非包膜组疗效差,骨化组只适用手术治疗。
肖莉, 王彦林, 董长宪, 孙斌 . 静脉畸形组织结构与治疗选择的临床分析[J]. 外科理论与实践, 2021 , 26(06) : 550 -554 . DOI: 10.16139/j.1007-9610.2021.06.018
Key words: Venous malformation; Tissue structure; Pathology
| [1] | Wieck MM, Nowicki D, Schall KA, et al. Management of pediatric intramuscular venous malformations[J]. J Pediatr Surg, 2017, 52(4):598-601. |
| [2] | Carqueja IM, Sousa J, Mansilha A. Vascular malformations: classification, diagnosis and treatment[J]. Int An-giol, 2018, 37(2):127-142. |
| [3] | Hage AN, Chick JFB, Srinivasa RN, et al. Treatment of venous malformations: the data, where we are, and how it is done[J]. Tech Vasc Interv Radiol, 2018, 21(2):45-54. |
| [4] | Zhong LP, Ow A, Yang WJ, et al. Surgical management of solitary venous malformation in the midcheek region[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012, 114(2):160-166. |
| [5] | Calandriello L, Grimaldi G, Petrone G, et al. Cavernous venous malformation (cavernous hemangioma) of the orbit: current concepts and a review of the literature[J]. Surv Ophthalmol, 2017, 62(4):393-403. |
| [6] | Jamshidi K, Jafari D, Ramezan Shirazi M, et al. An unusual presentation of ossified intramuscular hemangioma: a case report[J]. Acta Med Iran, 2014, 52(4):319-322. |
| [7] | Engelstad BL, Gilula LA, Kyriakos M. Ossified skeletal muscle hemangioma: radiologic and pathologic features[J]. Skeletal Radiol, 1980, 5(1):35-40. |
| [8] | Panda R, Mangal M, Reddy S, et al. Osseous metaplasia mimicking long bone in intramuscular vascualr malformation[J]. World J Plast Surg, 2018, 7(2):243-248. |
| [9] | Sadick M, Müller-Wille R, Wildgruber M, et al. Vascular anomalies(Part I): classification and diagnostics of vascular anomalies[J]. Rofo, 2018, 190(9):825-835. |
| [10] | 中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形的诊断及治疗指南(2019版)[J]. 组织工程与重建外科杂志, 2019, 15(5):277-317. |
| [11] | Clemens RK, Baumann F, Husmann M, et al. Percutaneous sclerotherapy for spongiform venous malformations-analysis of patient-evaluated outcome and satisfaction[J]. Vasa, 2017, 46(6):477-483. |
| [12] | Puig S, Aref H, Chigot V, et a1. Classification of venous malformations in children and implications for sclerothe-rapy[J]. Pediatr Radiol, 2003, 33(2):99-103. |
| [13] | Han YY, Sun LM, Yuan SM. Localized intravascular coa-gulation in venous malformations: a system review[J]. Phlebology, 2021, 36(1):38-42. |
| [14] | Dompmartin A, Acher A, Thibon P. Association of loca-lized intravascular coagulophathy with venous malformations[J]. Arch Dermatol, 2008, 144(7):873-877. |
| [15] | Binet Q, Lambert C, Hermans C. Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations[J]. Thromb Res, 2018, 168:114-120. |
| [16] | Aronniemi J, Castren E, Lappalainen K, et al. Sclerothe-rapy complications of peripheral venous malformations[J]. Phlebology, 2016, 31(10):712-722. |
| [17] | Legiehn GM. Sclerotherapy with adjunctive stasis of efflux(STASE) in venous malformations: techniques and strategies[J]. Tech Vasc Interv Radiol, 2019, 22(4):100630. |
/
| 〈 |
|
〉 |